Advertisement

Topics

Endocyte Incorporated Company Profile

05:29 EDT 17th October 2017 | BioPortfolio

Endocyte, Inc is a biotechnology company focused on vitamin based drug targeting and delivery systems. Vitamins are essential components for specific biological cellular functions. Endocyte's mission is to use vitamins as "trojan horses" to target and deliver diagnostic and therapeutic agents into cells for treatment of diseases. Endocyte's lead project is the use of the vitamin folate to target and deliver anticancer agents.

Location

1205 Kent Avenue
West Lafayette
IN
47906
United States of America

Contact

Phone: 765 463 7175
Fax: 765 463 9271


News Articles [27 Associated News Articles listed on BioPortfolio]

Endocyte slumps on staff and R&D cuts

Shares hit an all-time low as Endocyte "refocuses" and slashes workforce.

Endocyte to cut workforce 40%

Endocyte, a provider developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, announced updates on clinical development for EC1456, its folate ...

Endocyte in-licenses Phase III-ready PSMA-targeted radioligand therapy

US biopharma firm Endocyte has executed an exclusive worldwide license of PSMA-617 from ABX GmbH.

Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal

Four months after two Endocyte drug candidates stumbled in early-stage studies, sparking a corporate shakeup, the company has signed a deal landing an experimental prostate cancer treatment that it sa...

Endocyte licenses radioligand prostate cancer therapy from ABX GMBH

Endocyte Inc. received exclusive global rights to the radioligand therapeutic PSMA617 (177LuPSMA617) from ABX GMBH.

STAT Plus: How a whole lot of hype sent Endocyte’s stock soaring for no good reason

Endocyte's stock price has quadrupled since it licensed an experimental prostate cancer drug. Problem is, the drug is not likely to work — or sell — well.

Endocyte announces exclusive worldwide license of PSMA-targeted radioligand therapy for development in prostate cancer

Endocyte has announced the completion of an exclusive worldwide license of PSMA-617 from ABX GmbH.

Endocyte bounces back with late-stage prostate cancer deal

Endocyte saw its share price take off yesterday after it acquired rights to a promising late-stage cancer therapy. The company’s stock rose more than 150% in a day, with investors sensing that the ...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

AERODYNAMIC PROPERTIES AND IN SILICO DEPOSITION OF MELOXICAM POTASSIUM INCORPORATED IN A CARRIER-FREE DPI PULMONARY SYSTEM.

Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Extension Study of EC145 for Subjects Enrolled in a Previous Study With EC145

This extension protocol is for those subjects that have completed the allowed duration of participation in an Endocyte-sponsored clinical trial of EC145 and have continuing evidence of cli...

Companies [39 Associated Companies listed on BioPortfolio]

Endocyte Incorporated

Endocyte, Inc is a biotechnology company focused on vitamin based drug targeting and delivery systems. Vitamins are essential components for specific biological cellular functions. Endocyte's mission ...

Endocyte, Inc.

Endocyte is a privately held biotechnology company with headquarters in the Purdue Research Park of West Lafayette, IN. Based on the applications of Endocyte’s advanced propr...

Endocyte

Endocyte is developing a new generation of receptor-targeted therapeutics or "smart drugs" for the treatment of cancer and autoimmune diseases. Current non-targeted drugs are usually toxic to normal h...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Merck and Endocyte

Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines,...

More Information about "Endocyte Incorporated" on BioPortfolio

We have published hundreds of Endocyte Incorporated news stories on BioPortfolio along with dozens of Endocyte Incorporated Clinical Trials and PubMed Articles about Endocyte Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endocyte Incorporated Companies in our database. You can also find out about relevant Endocyte Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record